FIVE KEY STRATEGIES FOR ENHANCING DIVERSITY IN CLINICAL TRIALS

WASHINGTON, D.C -- The following information was released by the Pharmaceutical Research and Manufacturers of America (PhRMA): Report based on more than a year of research and feedback from more [...]